Menu Close

Parallel Session: Long-Term VTE-Related Complications in Cancer Patients



Dr Carmen Escalante
Professor and Chair, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, USA
Session Chair

Dr Carme Font
Medical Oncologist of the Urological Tumors Unit of HUV Macarena, Member of the board of directors of GETHI (Spanish Group of Orphan and Infrequent tumors) and and GECOD (Spanish Group of Unknown Primary Tumors), Spain
Session Chair

Dr Sergi Bellmunt Montoya
Head of Vascular Surgery and Angiology, Hospital Universitari Vall d’Hebron, Barcelona, Spain

Dr Luis Jara Palomares
Hospital Universitario Virgen del Rocío, Seville, Spain

Dr Nikolaos Tsoukalas
Medical Oncologist, On behalf of the Hellenic Society of Medical Oncology, Greece

Dr Nicolas Janus
Global Medical Manager, LEO Pharma A/S, Paris, France

Dr Florian Scotté
Oncologue médical, Chef du Département Interdisciplinaire d’Organisation des Parcours Patients (DIOPP), France

Dr Diego Muñoz Guglielmetti
Radiation Oncologist, Hospital Clínic de Barcelona, Spain


  • Post-Phlebitic Syndrome: Prevention and Management with Dr Sergi Bellmunt Montoya
  • Post-PE Syndrome: Evaluation of Patients with Thromboembolic Pulmonary Hypertension with Dr Luis Jara Palomares
  • Oral Proffered Paper 1: What Drives the Clinical Decision for Thromboprophylaxis in Active Cancer Patients? Perliminary Results of ACT4CAT Study Dr Nikolaos Tsoukalas
  • Oral Proffered Paper 2: Safety Profiles of Anticoagulants Using the EMA Pharmacovigilance Database with Prof Ismail Elalamy
  • Oral Proffered Paper 3: Treatment Compliance in Patients with Cat Receiving Lmwh: Learnings from Predicare, a Non-Interventional Prospective Cohort Study with Dr Florian Scotté
  • Oral Proffered Paper 4: Short-Term Outcomes of Cancer Patients with Pulmonary Embolism According to the Setting (Hospital-Acquired vs. Outpatient) at Diagnosis with Dr Diego Munoz Guglielmetti

Disclaimer: The views and opinions of presenters do not necessarily reflect those of MASCC or ISOO.